Revolution Medicines OverviewRevolution Medicines Other Income Expense Net
Other Income/Expense Net for RVMD.
Quarterly Other Income/Expense
-$8.59M
↓ 131.43% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$25.55M
↓ 71.98% YoY
Trailing 12 months ending Mar 31, 2026